SEC Form 4 · accession 0001209191-15-055512
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel N Swisher Jr.
Director
Period of report
Jun 18, 2015
Accepted (ET)
Jun 22, 2015 · 9:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock optionF1 | $6.55 | Jun 18, 2015 | A | 70,000 | D | — | Jun 18, 2025 | Common stock | 70,000 | 70,000 | D |
Explanation of responses
- F1Exercisable with respect to 25 percent of the total shares on June 18, 2016 and the remainder will vest ratably on each monthly anniversary thereafter such that the award will be fully vested on June 18, 2019.